TCG Crossover Management »

Gracell Biotechnologies shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Gracell Biotechnologies shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Gracell Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Gracell Biotechnologies held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Gracell Biotechnologies by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.8M 3.0M 2.88

More positions owned by TCG Crossover Management

Structure Therapeutics Adrs (GPCR)
Cogent Biosciences Comm (COGT)
Geron Corp Comm (GERN)
AN2 Therapeutics Comm (ANTX)
Savara Comm (SVRA)
Taysha Gene Therapies Comm (TSHA)
Kalvista Pharmaceuticals Comm (KALV)
Inhibrx Comm (INBX)
Aerovate Therapeutics Comm (AVTE)
Icosavax Comm
Compass Pathways Adrs (CMPS)
Ventyx Biosciences Comm (VTYX)
Tyra Biosciences Comm (TYRA)
Madrigal Pharmaceuticals Comm (MDGL)
Silence Therapeutics Adrs (SLN)

View all positions for TCG Crossover Management